ImmunityBio, Inc.IBRXNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank82
5Y CAGR-26.3%
Year-over-Year Change
Year-over-year book value per share growth
5Y CAGR
-26.3%/yr
Long-term compound
Percentile
P82
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 8.71% |
| Q3 2025 | 13.81% |
| Q2 2025 | 7.31% |
| Q1 2025 | -3.96% |
| Q4 2024 | 37.74% |
| Q3 2024 | -5.34% |
| Q2 2024 | 1.15% |
| Q1 2024 | -3.54% |
| Q4 2023 | -20.38% |
| Q3 2023 | 44.13% |
| Q2 2023 | -18.82% |
| Q1 2023 | -11.38% |
| Q4 2022 | -3.90% |
| Q3 2022 | -1.16% |
| Q2 2022 | -24.97% |
| Q1 2022 | -38.13% |
| Q4 2021 | -26.71% |
| Q3 2021 | -17.62% |
| Q2 2021 | 14.90% |
| Q1 2021 | -56.59% |
| Q4 2020 | 39.99% |
| Q3 2020 | -216.38% |
| Q2 2020 | 65.36% |
| Q1 2020 | -26.38% |
| Q4 2019 | 5.22% |
| Q3 2019 | -9.88% |
| Q2 2019 | -25.70% |
| Q1 2019 | 14.93% |
| Q4 2018 | -12.20% |
| Q3 2018 | -10.87% |
| Q2 2018 | -9.43% |
| Q1 2018 | -8.45% |
| Q4 2017 | -7.46% |
| Q3 2017 | -3.65% |
| Q2 2017 | -8.36% |
| Q1 2017 | -5.13% |
| Q4 2016 | -5.60% |
| Q3 2016 | -5.26% |
| Q2 2016 | -5.42% |
| Q1 2016 | -3.23% |